Michael G. Grey is an entrepreneur and businessperson who founded Mirum Pharmaceuticals, Inc., Reneo Pharmaceuticals, Inc. and Lumena Pharmaceuticals, Inc. and who has been at the helm of 17 different companies. Presently, Mr. Grey holds the position of Executive Chairman at Reneo Pharmaceuticals, Inc., Executive Chairman for Spruce Biosciences, Inc., Chairman of Mirum Pharmaceuticals, Inc., Executive Chairman of Plexium, Inc., Chairman for Sorriso Pharmaceuticals, Inc. and Venture partner at Pappas Capital LLC.
He is also on the board of Biothera, Inc., Horizon Therapeutics Plc and San Diego Venture Group.
In the past Michael G. Grey was Director at Curzion Pharmaceuticals, Inc., President & Chief Operating Officer for Ansan, Inc., Non-Executive Chairman at IDM Pharma, Inc., Executive Chairman for Amplyx Pharmaceuticals, Inc., Independent Director at Ziarco Pharma Ltd., Executive Chairman for Ziarco Group Ltd., President, Chief Executive Officer & Director at Trega Biosciences, Inc., President, Chief Executive Officer & Director at Lumena Pharmaceuticals, Inc., President & Chief Executive Officer of SGX Pharmaceuticals, Inc., President & Chief Operating Officer for Ansan Pharmaceuticals, Inc., President & Chief Executive Officer at Auspex Pharmaceuticals, Inc., President of Biochem Therapeutic, Inc., Vice President-Corporate Development at Glaxo, Inc. and Vice President-Corporate Development for Glaxo Holdings Plc.
He received an undergraduate degree from The University of Nottingham.